Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-26 @ 10:58 AM
NCT ID:
NCT01077206
Eligibility Criteria:
Inclusion criteria:
1. Patients (age 18-70 years) in which the admitting neurosurgeon has a high index of suspicion of a spontaneous aneurysmal subarachnoid haemorrhage with a convincing CT scan findings.
2. Any clinical grade accepted provided a reasonable prospect of survival.
3. Delay to randomization and initiation of trial medication from the time of the presenting ictus does not exceed 96 hours.
Exclusion criteria:
1. Unsalvageable patients: Fixed and dilated pupils after resuscitation, and/or a devastating scan, which preludes definitive therapy.
2. Already taking statin therapy.
3. Those taking Warfarin-type drugs.
4. Pregnancy.
5. Known renal or hepatic impairment.
6. Suspected or known additional disease process, which threatens life expectancy (e.g. malignancy).
7. Known or strong suspicion of drug abuse, alcoholism, or those who are likely to be amendable to 3 month follow up.
8. Those already taking amiodarone, verapamil or potent CYP3A4 inhibitors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01077206
Study Brief:
Protocol Section:
NCT01077206